Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001449,SPRD/Ztm,female,191 days to 186 days,48,,CMO:0000343,mammary tumor number,,,,11.23,,0.0736,0.51,MMO:0000344,necropsy,,0,necropsy,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11340,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001452,SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm,female,191 days to 186 days,14,,CMO:0000343,mammary tumor number,,,,3.93,,0.171,0.64,MMO:0000344,necropsy,,0,necropsy,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11341,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,191 days to 186 days,46,,CMO:0000343,mammary tumor number,,,,7.61,,0.0663,0.45,MMO:0000344,necropsy,,0,necropsy,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11342,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001449,SPRD/Ztm,female,118 days to 97 days,48,,CMO:0000344,mammary tumor growth rate,,the first 3 weeks of tumor growth,,0.7,cm/week,0.0043,0.03,MMO:0000160,unspecified method,,0.0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11346,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001452,SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm,female,128 days to 107 days,14,,CMO:0000344,mammary tumor growth rate,,the first 3 weeks of tumor growth,,0.62,cm/week,0.0214,0.08,MMO:0000160,unspecified method,,0.0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11347,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,120 days to 99 days,46,,CMO:0000344,mammary tumor growth rate,,the first 3 weeks of tumor growth,,0.79,cm/week,0.0074,0.05,MMO:0000160,unspecified method,,0.0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11348,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001449,SPRD/Ztm,female,102 days to 97 days,48,,CMO:0000345,post-insult time to mammary tumor formation,,,,43.8,d,0.1299,0.9,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11343,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001452,SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm,female,112 days to 107 days,14,,CMO:0000345,post-insult time to mammary tumor formation,,,,53.4,d,0.6414,2.4,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11344,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,104 days to 99 days,46,,CMO:0000345,post-insult time to mammary tumor formation,,,,45.91,d,0.1873,1.27,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11345,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) "